Resources

Novel Coronavirus (COVID-19) Patient Tracking Report—Wave 2

Wave 3 of this Tracking Report is now available here!

As the novel coronavirus (COVID-19) pandemic continues to develop in the US, InCrowd wanted to understand how experiences, perceptions, and predictions of patients who are immunocompromised or have chronic conditions have changed over the course of this crisis.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.

Methodology:

  • Method: 10-minute MicroSurvey via InCrowd & Rare Patient Voice
  • Crowds: Patients with Mild to Severe Illnesses
  • Sample Size: n=159 Total Patients (Previous Wave: 152), 83 Mild to Moderate Patients (Previous Wave: 77), 76 Moderate to Severe Patients (Previous Wave: 75)
  • Fielding Period: May 7th – 8th, 2020 (Previous Wave: March 25th – 26th)

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

Related Resources

Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more
Dobbs Decision After 18-Months 

Dobbs Decision After 18-Months 

HCP Perspectives 1 ½ Years After Dobbs v. Jackson Women’s Health Organization Our new Instant Insights report delves into the aftermath of the Dobb's decision, examining its impact on patients and healthcare professionals. Our objectives were threefold: Explore the...

read more